[Skip to Navigation]
Sign In
Views 99
Citations 0
Comment & Response
November 18, 2020

The Role of Bariatric Surgery in Prevention of Kidney Disease Progression in Moderately Obese Patients With Type 2 Diabetes

Author Affiliations
  • 1Imperial College London School of Medicine, London, England
  • 2Cardiff University School of Medicine, Cardiff, Wales
JAMA Surg. 2021;156(2):204-205. doi:10.1001/jamasurg.2020.5177

To the Editor We read with interest the study published by Cohen et al.1 This was a randomized clinical trial comparing the benefits of Roux-en-Y gastric bypass (RYGB) with best medical treatment (BMT) for chronic kidney disease in patients with type 2 diabetes and grade 1 obesity (body mass index of 30-35; calculated as weight in kilograms divided by height in meters squared).1 The authors concluded that RYGB is more effective at achieving microalbuminuria remission after 24 months and demonstrated it is a safe procedure with similar adverse effects to medical management.

Add or change institution
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words